TYLAN 50 FOR INJ 50MG DIN 00103586
Health Canada record
| Active ingredient(s) | TYLOSIN 50 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1968 |
| Current status date | 24-Sep-1999 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Division Eli Lilly Canada Inc — licence 101626, not currently licensed, last inspection rating C (2016-06-28).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TYLOSIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02295725 | NOROTYL LA (TYLOSIN INJECTABLE SUSPENSION) | NORBROOK LABORATORIES LTD. | Solution | TYLOSIN 150 MG | Cancelled Post Market |
| 00103594 | TYLAN 200 | ELANCO CANADA LIMITED | Solution | TYLOSIN 200 MG | Dormant |
| 00079219 | TYLOCINE INJ 200MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 200 MG | Cancelled Post Market |
| 00079200 | TYLOCINE INJ 50MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 50 MG | Cancelled Post Market |
| 00079227 | TYLOCINE TAB 200MG | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
| 01923803 | TYLOCINE TAB 200MG | ELI LILLY CANADA INC | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
International API supply for TYLOSIN
0 active FDA Drug Master Files.
Request a quote for TYLAN 50 FOR INJ 50MG